Submitted by sws139
on
PAD4 Autoimmune Disease Inhibitor
A team of Penn State scientists has devised a new strategy for “reactivating” genes that cause cancer tumors to shrink and die, and tested it in mice with to show that it reduces cancerous tumors in mice up to 70% without causing damage to healthy tissue. -Yanming Wang, 2014 LB2C Recipient.

We work together with the Office of Technology Management (OTM) and the Office for Industrial Partnerships (OIP), engaging in assisting inventors in capturing Intellectual Property (IP), and providing academic resources and support to entrepreneurs.